$ABBV has been mentioned 46 times by seven distinct FinTwit voices over a 12-month period from August 2025 to July 2026, with @jacobplieth accounting for 37 of those mentions and @adamfeuerstein contributing 11 mentions. The biotech category represents the most active discussion focus. The first mention in the archive appears on August 25, 2025, while the most recent mention occurred on July 17, 2026.

Recent discussion has centered on AbbVie's acquisition activity and its position within the Cell and Gene Therapy sector. In June 2026, @adamfeuerstein reported that "$ABBV buying $APGE $10.9B. Abbvie's press release," while @alphaticaio noted that "AbbVie is nearing a deal to acquire Apogee for $10.9B in cash" with the deal potentially announced as soon as Monday. As of mid-July 2026, @jacobplieth included $ABBV in a broader discussion of in vivo Car-T therapeutic approaches alongside competitors.